A Retrospective Exploration of Targeted Maintenance Therapy in Advanced Colorectal Cancer: Based on the Background of Chinese Patient Assistance Program

Background: Maintenance therapy with bevacizumab (Bev) in patients with colorectal cancer (CRC) provides progression-free survival (PFS) benefits. However, the role of maintenance therapy with an anti-EGFR monoclonal antibody has not been established. Methods: Eligible CRC patients were assigned to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hanguang, Liu, Xue, Cai, Wen, Wu, Dehao, Xu, Junxi, Yuan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190810/
https://www.ncbi.nlm.nih.gov/pubmed/32391263
http://dx.doi.org/10.3389/fonc.2020.00522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190810/
https://www.ncbi.nlm.nih.gov/pubmed/32391263
http://dx.doi.org/10.3389/fonc.2020.00522

Ejemplares similares